Guideline for Diazepam Use Prior to Magnetic Resonance Imaging (MRI)

Indications

Diazepam is recommended for patients experiencing anxiety that requires sedation to remain motionless during MRI scanning. 1
Diazepam is indicated when patient cooperation is essential to obtain diagnostic‑quality MRI images. 2

For elderly or debilitated adults, initiate oral diazepam at 2–2.5 mg with cautious titration as needed. 3

When immediate sedation is required, give an initial IV dose of 5–10 mg diazepam over 1 minute. 3
Additional IV doses may be administered at 5‑minute intervals if further sedation is needed. 3
In elderly patients, reduce the IV dose by 50 % or more compared with standard adult dosing. 3

For adults older than 60 years, reduce the dose by at least 20 % because of altered drug clearance. 3
No dose adjustment is necessary in patients with renal impairment, as diazepam is metabolized hepatically. 4
In patients with hepatic impairment, use diazepam with caution and apply a dose reduction. 3

Diazepam can cause dose‑dependent respiratory depression by suppressing the central ventilatory response to hypoxia and hypercapnia. 3
The risk of respiratory depression is higher in patients with underlying respiratory disease. 3
Oxygen saturation should be continuously monitored, and facilities for respiratory support must be readily available. 5

Avoid diazepam in patients with a history of severe contrast reactions when a contrast‑enhanced MRI is planned. 6

Continuously monitor vital signs and oxygen saturation throughout diazepam administration. 5
Keep flumazenil (0.2–0.4 mg IV) immediately available to reverse life‑threatening respiratory depression if it occurs. 3
Observe patients for a minimum of 2 hours after diazepam administration to ensure no resedation. 7

Paradoxical agitation may occur, particularly in younger children; discontinue diazepam immediately if this reaction is observed. 5

Midazolam is often preferred over diazepam for procedural sedation because it has a faster onset (1–2 minutes), shorter duration (15–80 minutes), and a more favorable safety profile. 3
Regular (repeated) use of sedatives in adult patients undergoing MRI is not recommended according to recent imaging guidelines. 1

The European Association of Nuclear Medicine (EANM) imaging guidelines state that when a sedative such as 5 mg diazepam is administered for procedural anxiety or claustrophobia during MRI, patients must be instructed not to drive and must travel home accompanied. 8
The FDA’s black‑box warning for benzodiazepines combined with other central nervous system depressants (e.g., opioids) emphasizes the risk of potentially fatal respiratory depression and sedation, reinforcing the need for a driver after administration. 9

Facilities must verify that patients have arranged transportation home before giving diazepam for MRI, ensuring a qualified driver is available. 8
A responsible adult must accompany the patient to and from the imaging center; when sedation risk is higher, two adults are preferred for transport. 10

Studies cited by the National Comprehensive Cancer Network demonstrate that even stable doses of benzodiazepine sedatives can impair psychomotor and cognitive function, so patients should not self‑assess fitness to drive after administration. 9
The requirement for a driver after procedural benzodiazepine sedation is absolute and non‑negotiable, as emphasized in the European nuclear medicine literature. 11